1.	Phase III Adjuvant Chemotherapy with Intravesical ADR Alone and in Combination with Systemic cis-Platinum and 5-FU in Adult Patients with Superficial Bladder Carcinoma Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MSUCTC-8417, NCI-V85-0102
2.	Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: Protocol IDs: EORTC-08881
3.	Phase III Study of Sucralfate Suspension vs Maalox/Benadryl/Viscous Lidocaine Cocktail to Treat Therapy-Associated Mucositis in Cancer Patients (Summary Last Modified 05/92) Phase: Phase III Type: Supportive care Status: Closed Age: 16 and over Sponsor: Protocol IDs: ICC-88CCN1, NCI-P89-0013, NCI-C88-0010
4.	Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MSKCC-7757
5.	Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia Phase: Phase II Type: Treatment Status: Closed Age: under 21 Sponsor: NCI Protocol IDs: POG-7818, MDAR-313
6.	Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children Phase: Phase II Type: Treatment Status: Closed Age: 18 and under Sponsor: NCI Protocol IDs: POG-7831, MDAR-319
7.	Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7734
8.	Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8120
9.	Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8116
10.	Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8118
11.	Phase II Chemotherapy with Bisantrene Hydrochloride for Advanced Hepatoma in Relapse Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8119
12.	Phase II Pilot Chemotherapy with Bisantrene Hydrochloride in Adults with Refractory Acute Leukemia Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: SWOG-8161
13.	Phase II Combination Chemotherapy (CTX/VCR/ACT-D or VBL/BLEO/CDDP) and/or Radiotherapy for Malignant Germ Cell Tumors in Children Phase: Phase II Type: Treatment Status: Closed Age: under 20 Sponsor: Protocol IDs: SJCRH-GCT-79
14.	Phase II Randomized Study of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients With Newly Diagnosed Cancer Phase: Phase II Type: Supportive care Status: Completed Age: 8 to 18 Sponsor: NCI Protocol IDs: SCUSF-0503, HLMCC-0503, SCUSF-0503, SCUSF 0503, NCT00429702
15.	Phase I Chemotherapy with Taxol for Carcinoma, Lymphoma, or Sarcoma Phase: Phase I Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: DFCI-83092, NCI-T84-0194W, T84-0194
16.	Induction by AZC/RBD and Maintenance by Repetitive Sequences of AZC/RBD, AZC/CTX, AZC/TG, AZC/VCR/DM for Acute Myelocytic Leukemia Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: CLB-7703
17.	Randomized Study of a Triple Antiemetic Combination Suppository Containing Metoclopramide/Dexamethasone/Diphenhydramine for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Summary Last Modified 07/90) Phase: No phase specified Type: Supportive care Status: Closed Age: 18 to 70 Sponsor: Protocol IDs: UKMC-87GYN03, NCI-V88-0455
18.	Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-13108, NCI-2010-01968, PEP-10-174-1-PCSM, NCT01204255